ICC Capital Management’s GSK GSK Stock Holding History

ICC Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$2.5M	Buy	43,426 +716	+2%	+$41K	0.33%	113
2014 Q4	$2.28M	Buy	42,710 +1,488	+4%	+$83.2K	0.3%	124
2014 Q3	$2.37M	Buy	41,222 +4,564	+12%	+$280K	0.29%	129
2014 Q2	$2.45M	Buy	36,658 +668	+2%	+$45.2K	0.26%	122
2014 Q1	$2.4M	Buy	35,990 +680	+2%	+$46K	0.22%	118
2013 Q4	$2.36M	Buy	35,310 +3,200	+10%	+$207K	0.2%	120
2013 Q3	$2.01M	Buy	32,110 +431	+1%	+$27.7K	0.15%	111
2013 Q2	$1.98M	Buy	+31,679	New	+$2.01M	0.14%	104

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ICC Capital Management's GSK Position: Q1 2015 in Review

ICC Capital Management increased its GSK (GSK) stake by 1.7% in Q1 2015, buying an estimated $41K and bringing the position to 43,426 shares worth $2.5M. The position accounts for 0.33% of the portfolio, ranked #113.

ICC Capital Management first reported a position in GSK in Q2 2013 and has held it in 8 quarters since. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

ICC Capital Management held 43,426 shares of GSK worth $2.5M as of Q1 2015.
ICC Capital Management bought 716 GSK shares in Q1 2015, an estimated $41K.
GSK made up 0.33% of ICC Capital Management's portfolio in Q1 2015, its #113 holding.
ICC Capital Management first reported a position in GSK in Q2 2013 and has held it in 8 quarters since.
740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on ICC Capital Management's 13F filing for Q1 2015, filed 13 May 2015.